Game Plan Financial Advisors’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Game Plan Financial Advisors’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-50	Closed	-$5	–	409
2024 Q3	$5	Hold	50	–	–	﹤0.01%	385
2024 Q2	$80	Hold	50	–	–	﹤0.01%	366
2024 Q1	$430	Hold	50	–	–	﹤0.01%	388
2023 Q4	$175	Buy	+50	New	+$176	﹤0.01%	418

Game Plan Financial Advisors's TCON Position: Q4 2024 in Review

Game Plan Financial Advisors sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q4 2024, closing a stake of 50 shares — an estimated $5 sold.

Game Plan Financial Advisors first reported a position in TCON in Q4 2023 and held it in 4 quarters. The position peaked at $430 in Q1 2024. 0 funds tracked by Wall St. Rank hold TCON as of Q4 2024.

Game Plan Financial Advisors reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Game Plan Financial Advisors sold 50 TRACON Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $5.
Game Plan Financial Advisors first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 4 quarters.
Game Plan Financial Advisors's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $430 in Q1 2024.
0 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Game Plan Financial Advisors's 13F filing for Q4 2024, filed 30 Jan 2025.